ReviewNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026
Epigenetic mechanisms of Parkinson's disease and potential epigenetic-based therapeutics.
Review in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundParkinson's disease (PD) is a chronic neurodegenerative disorder characterized by motor impairments and a spectrum of non-motor symptoms, including cognitive decline, depression, and autonomic dysfunction. The etiology of PD remains incompletely understood. Beyond genetic factors, environmental exposures and epigenetic modifications are believed to be pivotal in its pathogenesis. MAIN BODY: In recent years, epigenetic research on PD has identified multiple critical targets, thereby providing a theoretical foundation for the development of novel therapeutic strategies. Alterations in DNA methylation, histone modifications, and non-coding RNAs not only influence gene activity but also accelerate neuronal degeneration by regulating key pathways including oxidative stress and inflammatory responses. Consequently, epigenetics-based interventions represent a promising avenue for future PD therapy.
conclusionsThis article reviews how epigenetic processes contribute to the etiology of PD and explores potential epigenetics-based therapeutic approaches, thereby offering a valuable theoretical framework for future research in related fields.
Indexed as
Identifiers
41652241What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.